A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Raloxifene 6,4-bis-b-D-glucuronide | Raloxifene 6,4-bis-b-D-glucuronide, an enticing biomedical entity, manifests promising potential as a therapeutic agent targeting an array of ailments. Derived from Raloxifene, a selective estrogen receptor modulator (SERM), it serves as a glucuronide metabolite with a primary focus on tackling postmenopausal osteoporosis. Its remarkable aptitude in impeding bone resorption and preserving bone density renders it an efficacious choice in the management of osteoporosis-linked afflictions. Synonyms: (3R,4R,5R,6R)-6-[4-[6-[(2S,3S,4S,5S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid; Raloxifene 6,4'-Bis-beta-D-glucuronide; AKOS030241639; Raloxifene 6,4'-Bis- beta -D-glucuronide. CAS No. 182507-20-6. Molecular formula: C40H43NO16S. Mole weight: 825.85. |  |
| Raloxifene 6-D-glucuronide | Raloxifene 6-D-glucuronide is a formidable and discriminative estrogen receptor modulator (SERM), aiding in unraveling the intricate labyrinth of Raloxifene's metabolic pathways and elimination mechanisms. Synonyms: 2- (4-Hydroxyphenyl) -3-[4-2[2- (1-piperindinyl) ethoxybenzoyl]benzo[b]thien-6-yl]-b-D-glucopyranosiduronic acid. Molecular formula: C34H35NO10S. Mole weight: 649.71. | |
| Raloxifene 6-D-glucuronide D4 | Raloxifene 6-D-glucuronide D4 is a pharmacological compound for studying osteoporosand breast carcinoma acting as an estrogen receptor modifier. Molecular formula: C34H31NO10SD4. Mole weight: 653.73. | |
| Raloxifene-6-D-glucuronide D4 lithium salt | Raloxifene-6-D-glucuronide D4 lithium salt is a vital pharmaceutical compound extensively employed in the biomedical sector with application revolving around the research of osteoporosis in postmenopausal females. This compound functions as an extraordinary selective estrogen receptor modulator. Molecular formula: C34H30NO10SD4 Li. Mole weight: 659.66. | |
| Raloxifene-6-D-glucuronide lithium salt | Raloxifene-6-D-glucuronide lithium salt is a biomedical compound, used for studying the scourge of osteoporosand hormone receptor-positive breast cancer. It is perched as a lithium salt derivative of Raloxifene-6-D-glucuronide. Molecular formula: C34H34NO10S Li. Mole weight: 655.64. | |
| Raloxifene-6-glucuronide | A metabolite of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2- (4-Hydroxyphenyl) -3-[4-[2- (1-piperidinyl) ethoxybenzoyl]benzo[b]thien-6-yl]-β -D-glucopyranosiduronic Acid. Grades: > 95%. CAS No. 174264-50-7. Molecular formula: C34H35NO10S. Mole weight: 649.72. | |
| Raloxifene-6-Glucuronide Lithium Salt | A metabolite of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2- (4-Hydroxyphenyl) -3-[4-[2- (1-piperidinyl) ethoxybenzoyl]benzo[b]thien-6-yl]-β -D-glucopyranosiduronic Acid Lithium Salt. Grades: > 95%. Molecular formula: C34H34LiNO10S. Mole weight: 655.64. | |
| Raloxifene 6-Monomethyl Ether | Raloxifene 6-Monomethyl Ether. Group: Biochemicals. Alternative Names: [2- (4-Hydroxyphenyl) -6-methoxybenzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone. Grades: Highly Purified. CAS No. 178451-13-3. Pack Sizes: 10mg. Molecular Formula: C29H29NO4S, Molecular Weight: 487.61. US Biological Life Sciences. |  Worldwide |
| Raloxifene bismethyl ether | Raloxifene bismethyl ether. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone; [6-Methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone. Product Category: Heterocyclic Organic Compound. Appearance: Yellow Solid. CAS No. 84541-38-8. Molecular formula: C30H31NO4S. Mole weight: 501.64. Purity: 0.96. IUPACName: [6-methoxy-2-(4-methoxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone. Product ID: ACM84541388. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Raloxifene Bismethyl Ether | An intermediate in the synthesis of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 | Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 4-Glucuronide (4- [6-Hydroxy-3- [4- [2- (1-piperidinyl) ethoxy-d4]benzoyl]benzo [b]thien-2-yl]phenyl-ß-D-glucopyranosiduronic acid) | A labeled metabolite of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Alternative Names: 4- [6-Hydroxy-3- [4- [2- (1-piperidinyl) ethoxy-d4]benzoyl]benzo [b]thien-2-yl]phenyl-ß-D-glucopyranosiduronic acid. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 6,4-Bis(2,3,4,6-tetra-O-acetyl- β-D-glucuronide Methyl Ester) | An intermediate in the production of labeled Raloxifene metabolites. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 6,4-Bis- β-D-glucuronide | A labeled metabolite of Raloxifene. Group: Biochemicals. Alternative Names: 2-[4-( β -D-Glucopyranuronosyloxy) phenyl]-3- [4- [2- (1-piperidinyl) ethoxy-d4]benzoyl]benzo [b]thien-6-yl β-D-Glucopyranosiduronic Acid. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 6-Glucuronide (2-(4-Hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy-d4-benzoyl]benzo[b]thien-6-yl]-ß-D-glucopyranosiduronic acid) | A labeled metabolite of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Alternative Names: 2-(4-Hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy-d4-benzoyl]benzo[b]thien-6-yl]-ß-D-glucopyranosiduronic acid. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 Bismethyl Ether | An intermediate in the synthesis of deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4, Hydrochloride | Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene Dimethoxy Impurity | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Grades: > 95%. Molecular formula: C30H31NO4S. Mole weight: 501.65. | |
| Raloxifene EP Impurity A, N-oxide | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Grades: > 95%. Molecular formula: C42H44N2O8S. Mole weight: 736.89. | |
| Raloxifene EP IMpurity E | Raloxifene EP IMpurity E. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1700655-64-6. Molecular formula: C28H27NO4S. Mole weight: 473.59. Catalog: APB1700655646. |  |
| Raloxifene hydrochloride | Raloxifene hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 82640-04-8. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Raloxifene hydrochloride | Raloxifene hydrochloride (Keoxifene hydrochloride) is a second generation selective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue [1]. Uses: Scientific research. Group: Natural products. Alternative Names: Keoxifene hydrochloride; LY156758; LY139481 hydrochloride. CAS No. 82640-04-8. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg. Product ID: HY-13738A. |  |
| Raloxifene hydrochloride | Raloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used for prevention of osteoporosis in postmenopausal women. Uses: Prevention of osteoporosis in postmenopausal women. Synonyms: PD 0332991 isethionate; PD0332991 isethionate; PD-0332991 isethionate; Evista; Raloxifene Hcl; Keoxifene hydrochloride; (6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride. Grades: >98%. CAS No. 82640-04-8. Molecular formula: C28H28ClNO4S. Mole weight: 510.04. | |
| Raloxifene, Hydrochloride ( [6-Hydroxy-2- (4-hydroxyphenyl) -benzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone, Keoxifene, LY-139481) | A nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Alternative Names: [6-Hydroxy-2- (4-hydroxyphenyl) -benzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone, Keoxifene, LY-139481. Grades: Highly Purified. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Raloxifene (hydrochloride) (Standard) | Raloxifene (hydrochloride) (Standard) is the analytical standard of Raloxifene (hydrochloride). This product is intended for research and analytical applications. Raloxifene hydrochloride (Keoxifene hydrochloride) is a second generation selective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue [1]. Uses: Scientific research. Group: Natural products. Alternative Names: Keoxifene (hydrochloride)(Standard); LY156758(Standard); LY139481 (hydrochloride) (Standard). CAS No. 82640-04-8. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13738AR. | |
| Raloxifene Impurity 1 | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: [6-[ (Methylsulfonyl) oxy]-2-[4-[ (methylsulfonyl) oxy]phenyl]benzo[b]thien-3-yl][4-[2- (1-piperidinyl) ethoxy]phenyl]methanone Hydrochloride;Raloxifene Dimesylate Hydrochloride. Grades: > 95%. CAS No. 84449-85-4. Molecular formula: C30H31NO8S3. HCl. Mole weight: 666.24. | |
| Raloxifene Impurity 11 | Raloxifene Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1677681-02-5. Molecular formula: C18H22N2O4S. Mole weight: 362.44. Catalog: APB1677681025. | |
| Raloxifene Impurity 2 | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2-(4-Hydroxyphenyl)benzothiophene-6-ol. Grades: > 95%. CAS No. 63676-22-2. Molecular formula: C14H10O2S. Mole weight: 242.3. | |
| Raloxifene Impurity 3 | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2-[4-[ (Methylsulfonyl) oxy]phenyl]benzo[b]thien-6-yl methanesulfonate; 2-[4-[(Methylsulfonyl)oxy]phenyl]-benzo[b]thiophene-6-ol Methanesulfonate; Raloxifene Impurity; 2-(4-Hydroxyphenyl)benzo[b]thiophen-6-ol Bimesylate. Grades: > 95%. CAS No. 84449-65-0. Molecular formula: C16H14O6S3. Mole weight: 398.48. | |
| Raloxifene Impurity 6 (2-Ethyl-1-Benzothiophene) | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2-Ethylbenzo[b]thiophene. Grades: > 95%. CAS No. 1196-81-2. Molecular formula: C10H10S. Mole weight: 162.26. | |
| Raloxifene Impurity B | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: [6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-7-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone; Raloxifene Impurity C; [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-7-yl](4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone;3-Des[4-(2-Piperidinyl)ethoxy]benzoyl-7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene. Grades: > 95%. CAS No. 1391054-73-1. Molecular formula: C28H27NO4S. Mole weight: 473.6. | |
| Raloxifene Impurity C | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-oxido-1-piperidinyl)ethoxy]phenyl]methanone; USP Raloxifene Related Compound C; Raloxifene EP Impurity C; Raloxifene N-Oxide. Grades: > 95%. CAS No. 195454-31-0. Molecular formula: C28H27NO5S. Mole weight: 489.58. | |
| Raloxifene impurity D | Raloxifene impurity D. Group: Biochemicals. Grades: Highly Purified. CAS No. 177744-96-6. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 250mg. Molecular Formula: C21H14O4S. US Biological Life Sciences. | Worldwide |
| Raloxifene Impurity D | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl](4-hydroxyphenyl)methanone; LY 88074. Grades: > 95%. CAS No. 177744-96-6. Molecular formula: C21H14O4S. Mole weight: 362.41. | |
| Raloxifene Impurity III | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Grades: > 95%. Molecular formula: C14H19NO3. HCl. Mole weight: 285.77. | |
| Raloxifene N-oxide | Raloxifene N-oxide. Group: Biochemicals. Alternative Names: [6-Hydroxy-2- (4-hydroxyphenyl) benzo [b] thien-3-yl] [4- [2- (1-oxido-1-piperidinyl) ethoxy] phenyl] methanone; Raloxifene impurity C. Grades: Highly Purified. CAS No. 195454-31-0. Pack Sizes: 500mg. Molecular Formula: C28H27NO5S. US Biological Life Sciences. | Worldwide |
| Raloxifene N-Oxide | Raloxifene N-Oxide. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Raloxifene Imp. C (EP), Raloxifene USP RC C, Raloxifene N-Oxide,Raloxifene Hydrochloride Imp. C (EP), Raloxifene USP Related Compound C, [6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl][4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide. CAS No. 195454-31-0. IUPAC Name: [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-[2-(1-oxidopiperidin-1-ium-1-yl)ethoxy]phenyl]methanone. Molecular formula: C28H27NO5S. Mole weight: 489.58. Catalog: APS195454310. SMILES: Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCC[N+]5([O-])CCCCC5)cc4. Format: Neat. | |
| Raloxifene Related Compound C | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| R(-)-α-Chloromethyl Histamine Dihydrochloride | Histamine analog, with histamine-like activity. Group: Biochemicals. Alternative Names: α-(Chloromethyl)-1H-imidazole-4-ethanamine Dihydrochloride. Grades: Highly Purified. CAS No. 75614-86-7. Pack Sizes: 500mg. US Biological Life Sciences. | Worldwide |
| R-Alpha Lipoic Acid Sodium Salt | R-Alpha Lipoic Acid Sodium Salt. CAS No. 176110-81-9. |  CA, FL & NJ |
| R(-)-α-Methyl Histamine Dihydrochloride | Potent, selective H3 histamine receptor agonist which crosses the blood-brain barrier; inhibits histamine synthesis and release. Group: Biochemicals. Alternative Names: (αR)-. Grades: Highly Purified. CAS No. 75614-89-0. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| R-(?)-α-Methylhistamine hydrochloride | R-(-)-α-Methylhistamine is a histamine H3 receptor agonist that inhibits the synthesis and release of histamine. Synonyms: (R)-1-(1H-Imidazol-4-yl)propan-2-amine dihydrochloride. Grades: ≥95%. CAS No. 75614-89-0. Molecular formula: C6H11N3·2HCl. Mole weight: 198.1. | |
| R-(-)-α-Naphthyl Glycidyl Ether | Used in the preparation of Naftopidil enantiomers. Group: Biochemicals. Alternative Names: (2R)-. Grades: Highly Purified. CAS No. 56715-28-7. Pack Sizes: 500mg. US Biological Life Sciences. | Worldwide |
| R-(+)-alpha-Phenylethylamine | 100g Pack Size. Group: Amines, Building Blocks, Chiral Compounds, Organics. Formula: C8H11N. CAS No. 3886-69-9. Prepack ID 21032762-100g. Molecular Weight 121.18. See USA prepack pricing. |  |
| Ralphs Etchant | Ferritic stainless steels. Group: Etchants. |  |
| Raltegravir | Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Raltegravir;N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide;N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide;N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)p;Raltegravir(R&D);Raltegravir(free base);N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(2-(2-methyl-1,3,4-oxadiazole-5-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide;N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)am. Product Category: Inhibitors. Appearance: Solid. CAS No. 518048-05-0. Molecular formula: C20H21FN6O5. Mole weight: 444.42. Purity: 0.9953. Canonical SMILES: O=C(C(O)=C(C(NCC1=CC=C(C=C1)F)=O)N=C2C(C)(C)NC(C3=NN=C(C)O3)=O)N2C. Product ID: ACM518048050. Alfa Chemistry ISO 9001:2015 Certified. | |
| Raltegravir | Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection. Uses: Scientific research. Group: Signaling pathways. Alternative Names: MK-0518. CAS No. 518048-05-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg. Product ID: HY-10353. | |
| Raltegravir 2,3,4-Tri-O-acetyl- β-D-glucuronide Methyl Ester-d3 | Protected labeled metabolite of Raltegravir. Group: Biochemicals. Alternative Names: 4-[[[ (4-Fluorophenyl) methyl]amino]carbonyl]-1, 6-dihydro-1- (methyl-d3) -2-[1-methyl-1-[[ (5-methyl-1, 3, 4-oxadiazol-2-yl) carbonyl]amino]ethyl]-6-oxopyrimidin-5-yl. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raltegravir b-D-glucuronide methyl ester | Raltegravir b-D-glucuronide methyl ester is an invaluable pharmaceutical compound extensively applied in the biomedical industry, exhibiting profound application in studying human immunodeficiency virus (HIV) infections. It is renowned for its ability to inhibit HIV integrase enzyme. Synonyms: 4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxopyrimidin-5-yl-D-Glucopyranosiduronic Acid Methyl Ester. Molecular formula: C27H31FN6O11. Mole weight: 634.57. | |
| Raltegravir beta-D-glucuronide | Raltegravir beta-D-glucuronide. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 952654-62-5, Raltegrav, ir.beta.-D-glucuronide, Raltegravir |A-D-Glucuronide, 4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxopyrimidin-5-yl |A-D-Glucopyranosiduronic Acid, beta.-D-Glucopyranosiduronic acid, 4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxopyrimidin-5-yl. Product Category: Heterocyclic Organic Compound. CAS No. 952654-62-5. Molecular formula: C26H29FN6O11. Mole weight: 620.54. Purity: 0.96. IUPACName: (2S,3S,4S,5R,6S)-6-[4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid. Density: 1.664g/cm³. Product ID: ACM952654625. Alfa Chemistry ISO 9001:2015 Certified. | |
| Raltegravir β-D-Glucuronide | A metabolite of Raltegravir.Raltegravir is an integrase inhibitor as antiretroviral drug. It can be used for the treatment of HIV infection. Synonyms: 4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxopyrimidin-5-yl β-D-Glucopyranosiduronic Acid. Grades: > 95%. CAS No. 952654-62-5. Molecular formula: C26H29FN6O11. Mole weight: 620.54. | |
| Raltegravir β-D-Glucuronide Methyl Ester-d3 | Protected, labeled metabolite of Raltegravir. Group: Biochemicals. Alternative Names: 4-[[[ (4-Fluorophenyl) methyl]amino]carbonyl]-1, 6-dihydro- (1-methyl-d3) -2-[1-methyl-1-[[ (5-methyl-1, 3, 4-oxadiazol-2-yl) carbonyl]amino]ethyl]-6-oxopyrimidin-5-yl. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raltegravir-d3 β-D-Glucuronide | A labeled metabolite of Raltegravir. Group: Biochemicals. Alternative Names: 4-[[[ (4-Fluorophenyl) methyl]amino]carbonyl]-1, 6-dihydro-1-methyl-2-[1-methyl-1-[[ (5-methyl-1, 3, 4-oxadiazol-2-yl) carbonyl]amino]ethyl]-6-oxopyrimidin-5-yl. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raltegravir-d3 Potassium Salt | A potent human immunodeficiency virus (HIV) integrase inhibitor. A novel anti-AIDS drug. Group: Biochemicals. Alternative Names: N-[ (4-Fluorophenyl) methyl]-1, 6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[ (5-methyl-1, 3, 4-oxadiazol-2-yl) carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide-d3 Potassium Salt. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raltegravir potassium | Raltegravir (MK 0518) potassium is a potent integrase (IN) inhibitor, used to treat HIV infection. Uses: Scientific research. Group: Signaling pathways. Alternative Names: MK 0518 potassium. CAS No. 871038-72-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-10353A. | |
| Raltegravir Potassium Salt | Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM). It is metabolized primarily by uridine diphosphate glucuronosyltransferase 1A. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents. Uses: Anti-hiv agents. Synonyms: MK-0518; MK 0518; MK0518; Raltegravir. Grades: 98%. CAS No. 871038-72-1. Molecular formula: C20H20FKN6O5. Mole weight: 482.514. | |
| Raltegravir Potassium Salt | A potent human immunodeficiency virus (HIV) integrase inhibitor. A novel anti-AIDS drug. Group: Biochemicals. Alternative Names: N-[ (4-Fluorophenyl) methyl]-1, 6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[ (5-methyl-1, 3, 4-oxadiazol-2-yl) carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide Potassium Salt. Grades: Highly Purified. CAS No. 871038-72-1. Pack Sizes: 2.5mg. US Biological Life Sciences. | Worldwide |
| Raltegravir Related Compound E | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Raltitrexed | ?98% (HPLC), solid. Group: Fluorescence/luminescence spectroscopy. | |
| Raltitrexed | Raltitrexed is an antimetabolite agent used in chemotherapy, acting by inhibiting thymidylate synthase. Uses: Scientific research. Group: Signaling pathways. Alternative Names: ZD1694; D1694; ICI-D1694. CAS No. 112887-68-0. Pack Sizes: 10 mM * 1 mL; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10821. | |
| Raltitrexed | Raltitrexed is a thymidylate synthase inhibitor with an IC50 of 9 nM for the inhibition of L1210 cell growth. Raltitrexed is used as an antimetabolite drug used in the treatment of colorectal cancer, and may be beneficial for malignant mesothelioma treatment. Uses: The treatment of colorectal cancer. Synonyms: Tomudex; ZD1694; ZD-1694; ICI-D1694; (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid. Grades: > 98%. CAS No. 112887-68-0. Molecular formula: C21H22N4O6S. Mole weight: 458.49. | |
| Raltitrexed | Raltitrexed. Group: Biochemicals. Alternative Names: N-[[5-[[ (1, 4-Dihydro-2-methyl-4-oxo-6-quinazolinyl) methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic acid; Tomudex; ICI-D-1694. Grades: Highly Purified. CAS No. 112887-68-0. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C21H22N4O6S. US Biological Life Sciences. | Worldwide |
| Raltitrexed monohydrate | Raltitrexed monohydrate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: L-Glutamic acid, N-((5-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thienyl)carbonyl)-monohydrate;ICI-D-1694. Product Category: Thiophenes. Appearance: Yellow Solid. CAS No. 112887-68-0. Molecular formula: C21H22N4O6S·H2O. Mole weight: 476.5. Purity: 0.99. Product ID: ACM112887680. Alfa Chemistry ISO 9001:2015 Certified. | |
| Raltitrexed (N-[[5-[[ (1, 4-Dihydro-2-methyl-4-oxo-6-quinazolinyl) methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic Acid, Tomudex, ICI-D-1694, ZD-1694) | Folate-based inhibitor of thymidylate synthase; rapidly and extensively metabolized to its more potent polyglutamate derivatives. Antineoplastic. Group: Biochemicals. Alternative Names: N-[[5-[[ (1, 4-Dihydro-2-methyl-4-oxo-6-quinazolinyl) methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic Acid; Tomudex; ICI-D-1694; ZD-1694. Grades: Highly Purified. CAS No. 112887-68-0. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Raludotatug | Raludotatug is a humanized immunoglobulin G1-kappa, anti-CDH6 monoclonal antibody. Raludotatug is an antineoplastic [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 2610074-56-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990028. | |
| Raludotatug Deruxtecan | Raludotatug Deruxtecan (DS-6000) is a novel antibody conjugate (ADC) targeting CDH6. Raludotatug Deruxtecan is conjugated with Raludotatug (HY-P990028) and Deruxtecan (HY-13631E). Raludotatug Deruxtecan can be used in the research of ovarian cancer and renal cancer. Uses: Scientific research. Group: Signaling pathways. Alternative Names: R-DXd; DS-6000. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-164734. | |
| RALUFON (R) NO 14 | RALUFON (R) NO 14. Uses: Designed for use in research and industrial production. Additional or Alternative Names: oxirane,methyl-,polymerwithoxirane,mono-2-naphthalenylether;RALUFON (R) NO 14;Methyl oxirane polymer with oxirane, mono-2-naphthalenyl ether. Product Category: Heterocyclic Organic Compound. CAS No. 63950-87-8. Product ID: ACM63950878. Alfa Chemistry ISO 9001:2015 Certified. | |
| Raluridine | Raluridine is a uridine analogue with activity against HIV-1 and HIV-2 in vitro. Synonyms: FddClU; 5-Chloro-2',3'-dideoxy-3'-fluorouridine; 2',3'-Dideoxy-3'-fluoro-5-chlorouridine; 5-Chloro-1-((2R,4S,5R)-4-fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; Fddclurd; 3'-Fluoro-2',3'-dideoxy-5-chlorouridine; 5-Chloro-3'-fluoro-2',3'-dideoxyuridine; BW 935U83; GW 274666X. Grades: ≥95%. CAS No. 119644-22-3. Molecular formula: C9H10ClFN2O4. Mole weight: 264.64. | |
| Ramacemide | Ramacemide. Uses: Designed for use in research and industrial production. Additional or Alternative Names: (+/-)-2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide;Ramacemide;(+/-)-2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide;2-amino-N-[1,2-di(phenyl)propan-2-yl]acetamide;2-azanyl-N-[1,2-di(phenyl)propan-2-yl]ethanamide. Product Category: Heterocyclic Organic Compound. CAS No. 128298-28-2. Molecular formula: C17H20N2O. Mole weight: 268.35. Product ID: ACM128298282. Alfa Chemistry ISO 9001:2015 Certified. Categories: Remacemide. | |
| Ramage Linker | Ramage Linker, also known as Ramage-Linker can be used for preparation of peptide amides specially as an acid-labile peptide amide linker. Synonyms: Fmoc-suberol; 2-[[5-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-2-yl]oxy]acetic Acid; (R,S)-2-[[5-(9-FLUORENYLMETHYLOXYCARBONYLAMINO)-DIBENZO[A,D]CYCLOHEPTANE-2-YL]OXY]-ACETIC ACID; 5-FMoc-aMino-2-carboxyMethoxy-10,11-dihydro-5H-dibenzo[a,d]cycloheptene; Fmoc-Suberol; 5-FMOC-AMINO-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTENE-2-HYDROXY ACETIC ACID; REF DUPL: Ramage Linker,Fmoc-Suberol. Grades: 98% (HPLC). CAS No. 212783-75-0. Molecular formula: C32H27NO5. Mole weight: 505.56. | |
Our database is helping our users find suppliers everyday.
